Original Article

You have full text access to this OnlineOpen article

Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens

  1. Yongjin Wang MD1,
  2. Richard Tsang MD1,
  3. Sylvia Asa MD, PhD2,
  4. Brendan Dickson MD2,
  5. Tamara Arenovich MSc3,
  6. James Brierley MB1,†,*

Article first published online: 11 SEP 2006

DOI: 10.1002/cncr.22203

Issue

Cancer

Cancer

Volume 107, Issue 8, pages 1786–1792, 15 October 2006

Additional Information

How to Cite

Wang, Y., Tsang, R., Asa, S., Dickson, B., Arenovich, T. and Brierley, J. (2006), Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens. Cancer, 107: 1786–1792. doi: 10.1002/cncr.22203

Author Information

  1. 1

    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada

  2. 2

    Department of Pathology, Princess Margaret Hospital, Toronto, Ontario, Canada

  3. 3

    Department of Biostatistics, Princess Margaret Hospital, Toronto, Ontario, Canada

  1. †

    Fax: (416) 946-6566.

*Department of Radiation Oncology, Princess Margaret Hospital, 610 University Ave., Rm. 5-627, Toronto, ON M5G 2M9 Canada

Publication History

  1. Issue published online: 3 OCT 2006
  2. Article first published online: 11 SEP 2006
  3. Manuscript Accepted: 10 JUL 2006
  4. Manuscript Revised: 28 JUN 2006
  5. Manuscript Received: 2 MAY 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (112K)

REFERENCES

  • 1
    Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer. 1998; 83: 2638–2648.
    Direct Link:
  • 2
    Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab. 1999; 84: 4043–4049.
  • 3
    Pasieka JL. Anaplastic thyroid carcinoma. Curr Opin Oncol. 2003; 15: 78–83.
  • 4
    Sniezek JC. Rare tumors of the thyroid gland. Otolaryngol Clin North Am. 2003; 36: 107–115.
  • 5
    Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma treatment outcome and prognostic factors. Cancer. 2005; 103: 1330–1335.
    Direct Link:
  • 6
    International Union Against Cancer. TNM classification of malignant tumours, 6th ed. New York: Wiley-Liss, 2002.
  • 7
    American Joint Committee on Cancer. AJCC cancer staging manual, 6th ed. New York: Springer, 2002.
  • 8
    Nel CJ, van Heerden JA, Goellner JR, et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc. 1985; 60: 51–58.
  • 9
    Tan RK, Finley RK3rd, Driscoll D, Bakamjian V, Hicks WLJr., Shedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck. 1995; 17: 41–48.
    Direct Link:
  • 10
    Passler C, Scheuba C, Prager G, et al. Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg. 1999; 384: 284–293.
  • 11
    Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol. 2002; 9: 57–64.
  • 12
    De Crevoisier R, Baudin E, Bachelot A, et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiation Oncology Biol Phys. 2004; 60: 1137–1143.
  • 13
    Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol. 1992; 18: 83–88.
  • 14
    Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid. 2000; 10: 587–594.
  • 15
    Schlumberger M, Parmentier C, Delisle MJ, Couette JE, Droz JP, Sarrazin D. Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer. 1991; 67: 564–566.
    Direct Link:
  • 16
    Hoskin PJ, Harmer C. Chemotherapy for thyroid cancer. Radiother Oncol. 1987; 10: 187–194.
  • 17
    Shimaoka K, Schoenfeld DA, DeWys WD, Creech RH, DeConti R. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer. 1985; 56: 2155–2160.
    Direct Link:
  • 18
    McIver B, Hay ID, Giuffrida DF, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001; 130: 1028–1034.
  • 19
    Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic thyroid carcinoma Group. Cancer. 1994; 74: 1348–1354.
    Direct Link:
  • 20
    Nilsson O, Lindeberg J, Zedenius J, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg. 1998; 22: 725–730.
  • 21
    Tennvall J, Lundell G, Wahlberg P, et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer. 2002; 86: 1848–1853.
  • 22
    Werner B, Abele J, Alveryd A, et al. Multimodal therapy in anaplastic giant cell thyroid carcinoma. World J Surg. 1984; 8: 64–70.
  • 23
    Kim JH, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer. 1987; 60: 2372–2375.
    Direct Link:
  • 24
    Mitchell G, Huddart R, Harmer C. Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol. 1999; 50: 33–38.
  • 25
    Wong CS, Van Dyk J, Simpson WJ. Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol. 1991; 20: 3–9.
  • 26
    Haigh PI, Ituarte PH, Wu HS, et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer. 2001; 91: 2335–2342.
    Direct Link:
View Full Article (HTML) Get PDF (112K)